摘要
目的:探讨甲亢患者β2-微球蛋白含量与血脂水平的相关性。方法:以甲状腺功能亢进症患者40例作为观察组,另选择同期在我院进行体检的健康人群40例为对照组,分别于治疗前和治疗后检测患者血清和尿β2-微球蛋白、血外周血载脂蛋白、血脂,并进行血清和尿β2-微球蛋白与血脂的相关性分析。结果:治疗前甲亢组血清和尿β2-微球蛋白均高于对照组(P<0.01);TC、TG、HDL-C、LDL-C和APOB均低于对照组(P<0.01);治疗后,血清和尿β2-微球蛋白与治疗前相比均有所下降(P<0.01),TC、TG、HDL-C、LDL-C和APOB与脂类前相比均有所升高(P<0.01);血清和尿β2-微球蛋白与TC、TG、HDL-C、LDL-C和APOB均呈负相关。结论:甲亢患者血清和尿β2-微球蛋白与血脂关系密切,可作为评价患者脂质代谢状态和病情变化的重要指标。
Objective: To explore the relationship between β 2-microglobulin and blood fat in patients with Graves' disease. Methods: 40 patients with Graves' disease were selected as observation group, and 40 healthy people were selected as controi group. To detect serum, urine contents of β 2-microglobulin, APOB and blood fat before and after treatment. To analyze the relationship of the serum, urine contents of β 2-microglobulin and blood fat. Results: The levels of serum, urine of β2-microglobulin were higher in observation group than those in control group before treatment, while the level of TC, TG, HDL-C, LDL-C and APOB were lower in observation group than those in control group. The levels of serum, urine of β 2-microglobulin decreased in observation group after treatment compared with those before treatment, while the level of TC, TG, HDL-C, LDL-C and APOB increased after treatment compared with those before treatment. The levels of serum, urine of β 2-microglobulin were negative correlation to the levels of TC, TG, HDL-C, LDL-C and APOB. Conclusion: There is a closely relationship between β 2-microglobulin and blood fat in patients with Graves' disease. β 2-microglobulin can be used to value metabolism of blood fat and the change of pathogenetic condition.
出处
《现代生物医学进展》
CAS
2011年第21期4095-4097,共3页
Progress in Modern Biomedicine
基金
海南省卫生厅科研课题(琼卫2009-32)